Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126896101 | 12689610 | 1 | I | 20160628 | 20160418 | 20160826 | 20160826 | EXP | ZA-ROCHE-1747734 | ROCHE | 74.35 | YR | M | Y | 0.00000 | 20160826 | OT | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126896101 | 12689610 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Other | IN LEFT EYE | S0090 | 125156 | SOLUTION FOR INJECTION | ||||||||
| 126896101 | 12689610 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | CYCLE 2?LEFT EYE | S0090 | 125156 | SOLUTION FOR INJECTION | ||||||||
| 126896101 | 12689610 | 3 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | CYCLE 2?LEFT EYE | S0090 | 125156 | SOLUTION FOR INJECTION | ||||||||
| 126896101 | 12689610 | 4 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | CYCLE 2?LEFT EYE | S0090 | 125156 | SOLUTION FOR INJECTION | ||||||||
| 126896101 | 12689610 | 5 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | CYCLE 2?LEFT EYE | S0090 | 125156 | SOLUTION FOR INJECTION | ||||||||
| 126896101 | 12689610 | 6 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | CYCLE 2?LEFT EYE | S0090 | 125156 | SOLUTION FOR INJECTION | ||||||||
| 126896101 | 12689610 | 7 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | CYCLE 3 | S0090 | 125156 | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126896101 | 12689610 | 1 | Neovascular age-related macular degeneration |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126896101 | 12689610 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126896101 | 12689610 | Blepharitis | |
| 126896101 | 12689610 | Choroidal neovascularisation | |
| 126896101 | 12689610 | Dacryocanaliculitis | |
| 126896101 | 12689610 | Detachment of retinal pigment epithelium | |
| 126896101 | 12689610 | Macular degeneration | |
| 126896101 | 12689610 | Retinal oedema | |
| 126896101 | 12689610 | Retinal thickening |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126896101 | 12689610 | 1 | 20151203 | 0 | ||
| 126896101 | 12689610 | 2 | 20160111 | 0 | ||
| 126896101 | 12689610 | 3 | 20160310 | 0 | ||
| 126896101 | 12689610 | 4 | 20160412 | 0 | ||
| 126896101 | 12689610 | 5 | 20160524 | 0 | ||
| 126896101 | 12689610 | 6 | 20160628 | 0 | ||
| 126896101 | 12689610 | 7 | 20160811 | 0 |